Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA006295 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA006295, RRID:AB_1079975
- Product name
- Anti-SIRT1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SIRT1, Gene description: sirtuin 1, Alternative Gene Names: SIR2L1, Validated applications: IHC, ICC, Uniprot ID: Q96EB6, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references SIRT1 Expression and Regulation in the Primate Testis
Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors
Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer.
Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis.
Direct Transcriptional Effects of Apolipoprotein E
Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia
SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
Wahab F, Rodriguez Polo I, Behr R
International Journal of Molecular Sciences 2021;22(6):3207
International Journal of Molecular Sciences 2021;22(6):3207
Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors
Schmid N, Dietrich K, Forne I, Burges A, Szymanska M, Meidan R, Mayr D, Mayerhofer A
International Journal of Molecular Sciences 2021;22(4):2047
International Journal of Molecular Sciences 2021;22(4):2047
Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer.
Beyer S, Chen F, Meister S, Czogalla B, Kolben TM, Hester A, Burges A, Trillsch F, Schmöckel E, Mayr D, Mayerhofer A, Mahner S, Jeschke U, Kolben T
Histochemistry and cell biology 2020 Aug;154(2):189-195
Histochemistry and cell biology 2020 Aug;154(2):189-195
Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis.
Brandl L, Zhang Y, Kirstein N, Sendelhofert A, Boos SL, Jung P, Greten F, Rad R, Menssen A
Neoplasia (New York, N.Y.) 2019 Oct;21(10):974-988
Neoplasia (New York, N.Y.) 2019 Oct;21(10):974-988
Direct Transcriptional Effects of Apolipoprotein E
Theendakara V, Peters-Libeu C, Spilman P, Poksay K, Bredesen D, Rao R
The Journal of Neuroscience 2016;36(3):685-700
The Journal of Neuroscience 2016;36(3):685-700
Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia
Itkin-Ansari P, Pinho A, Bensellam M, Wauters E, Rees M, Giry-Laterriere M, Mawson A, Ly L, Biankin A, Wu J, Laybutt D, Rooman I
PLOS ONE 2015;10(6):e0128012
PLOS ONE 2015;10(6):e0128012
SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
Noguchi A, Kikuchi K, Zheng H, Takahashi H, Miyagi Y, Aoki I, Takano Y
Cancer Medicine 2014;3(6):1553-1561
Cancer Medicine 2014;3(6):1553-1561
No comments: Submit comment
No validations: Submit validation data